By clicking “Accept All Cookies” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Privacy PolicyFlexible Endoscopy Equipment Market (By Type: Colonoscopes, Gastroscopes, Bronchoscopes, and Others; By Application: Hospitals, Ambulatory Surgical Centers/Clinics, and Others; By Region: North America, Europe, Asia Pacific, and LAMEA) Industry Size, Share, Growth, Trends 2025 to 2034
The global flexible endoscopy equipment market size was evaluated at USD 3,476 million in 2024 and is expected to grow around USD 8,305 million by 2034 with a CAGR of 9.1%. Driven by the rising need for specialized healthcare screening. The market is witnessing strong growth as the demand for minimally invasive diagnostic and surgical procedures continues to increase globally. Flexible endoscopy equipment has revolutionized medical imaging and diagnosis, offering greater maneuverability and precision compared to traditional rigid endoscopes. These devices use flexible, bendable tubes that can navigate the body’s natural pathways, making them essential for procedures such as gastroscopies, colonoscopies, and bronchoscopies. The growing incidence of gastrointestinal and respiratory diseases, particularly among older populations, continues to support market expansion.
| Reports Attributes | Statistics |
| Market Size in 2024 | USD 3,476 Million |
| Market Size in 2025 | USD 3,792 Million |
| Market Size in 2031 | USD 6,395 Million |
| Market Size by 2034 | USD 8,305 Million |
| CAGR 2025 to 2034 | 9.1% |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
Technological advancements in imaging, optics, and material design have enhanced the capabilities of flexible endoscopes, leading to faster recovery times and reduced patient discomfort. The growing emphasis on early disease detection and preventive care is further driving demand for these devices. The healthcare sector’s increasing focus on minimally invasive treatments has created a favorable environment for the adoption of flexible endoscopy systems across hospitals, clinics, and ambulatory surgical centers. North America and Europe are currently leading markets due to strong healthcare infrastructure, while the Asia-Pacific region is emerging as a high-growth hub supported by rising healthcare investments and improving access to diagnostic technologies.
The key drivers of market growth include the rising prevalence of chronic gastrointestinal and respiratory disorders, growing adoption of minimally invasive surgeries, and rapid advancements in imaging technology. Flexible endoscopes allow clinicians to visualize internal organs in detail, improving diagnostic accuracy and reducing the need for open surgical procedures. The increasing aging population, which is more susceptible to chronic conditions such as colorectal cancer and gastroesophageal reflux disease, is further stimulating demand.
Additionally, the ongoing shift toward outpatient and day-care procedures has encouraged hospitals and clinics to invest in efficient, portable, and cost-effective endoscopic equipment. The combination of high-resolution imaging, enhanced flexibility, and improved ergonomics has positioned flexible endoscopes as a preferred diagnostic tool in modern healthcare settings.
The flexible endoscopy equipment market faces several challenges, particularly in underdeveloped and emerging regions. The high initial investment required for advanced endoscopic systems can limit adoption among smaller healthcare facilities. Maintenance and training costs add further strain, as skilled professionals are essential for operating these devices effectively. Moreover, the limited availability of infrastructure and reimbursement challenges can restrict the use of these technologies in low-income regions.
Despite these barriers, the market offers substantial opportunities. The growing digitization of healthcare and the integration of smart technologies are enabling new business models for manufacturers. The use of connected systems allows for data sharing, remote diagnostics, and improved patient monitoring. Governments across emerging markets are investing in healthcare modernization programs, such as China’s “Healthy China 2030,” which aims to enhance early cancer detection and treatment capabilities. These initiatives are expected to generate strong demand for flexible endoscopy equipment in the coming decade.
Artificial Intelligence and robotics are reshaping the flexible endoscopy landscape by enhancing precision, safety, and diagnostic accuracy. AI-powered algorithms are being used to detect early signs of cancer, lesions, and other abnormalities in real time, improving the reliability of diagnostic results. Machine learning models analyze patient data to assist clinicians in making faster and more informed decisions.
The integration of robotic technology in flexible endoscopy procedures is helping reduce operator fatigue, improve control, and increase success rates in complex procedures. These technologies also enable automation in navigation and imaging, minimizing human error and improving patient outcomes. As AI and robotics continue to mature, they are expected to make flexible endoscopy procedures safer, more efficient, and more accessible worldwide.
The flexible endoscopy equipment market is expected to grow steadily as healthcare systems embrace innovation, preventive care, and digital transformation. The convergence of robotics, AI, and advanced imaging will continue to redefine diagnostic and surgical capabilities. Developed regions will maintain their leadership due to continued investment in medical technology, while Asia-Pacific and the Middle East are likely to experience the fastest growth with rising healthcare spending and improved accessibility.
In the years ahead, flexible endoscopy will become an even more integral part of diagnostic medicine. The continued development of lightweight, smart, and connected endoscopic devices will enhance efficiency and improve patient experiences, positioning the market for sustainable growth across global healthcare systems.
| Regions | Shares (%) |
| North America | 35% |
| Asia Pacific | 25% |
| Europe | 30% |
| LAMEA | 10% |
| Segments | Shares (%) |
| Colonoscopes | 35% |
| Gastroscopes | 30% |
| Bronchoscopes | 20% |
| Others | 15% |
| Segments | Shares (%) |
| Hospitals | 60% |
| Ambulatory Surgical Centers/Clinics | 30% |
| Others | 10% |
Published by Kesiya Chacko
| Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Colonoscopes | 1,216.60 | 1,319.73 | 1,431.55 | 1,552.79 | 1,684.24 | 1,826.77 | 1,981.27 | 2,148.78 | 2,330.37 | 2,527.21 | 2,740.57 |
| Gastroscopes | 1,042.80 | 1,141.49 | 1,249.50 | 1,367.72 | 1,497.11 | 1,638.72 | 1,793.70 | 1,963.32 | 2,148.96 | 2,352.13 | 2,574.48 |
| Bronchoscopes | 695.20 | 766.05 | 844.03 | 929.87 | 1,024.34 | 1,128.30 | 1,242.69 | 1,368.57 | 1,507.06 | 1,659.43 | 1,827.05 |
| Others | 521.40 | 565.06 | 612.34 | 663.55 | 719 | 779.06 | 844.09 | 914.51 | 990.76 | 1,073.30 | 1,162.67 |
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 2,085.60 | 2,267.81 | 2,465.90 | 2,681.27 | 2,915.42 | 3,169.98 | 3,446.71 | 3,747.58 | 4,074.66 | 4,430.22 | 4,816.76 |
| Ambulatory Surgical Centers/Clinics | 1,042.80 | 1,145.28 | 1,257.78 | 1,381.26 | 1,516.80 | 1,665.58 | 1,828.87 | 2,008.09 | 2,204.78 | 2,420.64 | 2,657.52 |
| Others | 347.60 | 379.23 | 413.74 | 451.39 | 492.47 | 537.28 | 586.18 | 639.52 | 697.72 | 761.21 | 830.48 |
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1,216.60 | 1,319.73 | 1,431.55 | 1,552.79 | 1,684.24 | 1,826.77 | 1,981.27 | 2,148.78 | 2,330.37 | 2,527.21 | 2,740.57 |
| Europe | 1,042.80 | 1,133.90 | 1,232.95 | 1,340.63 | 1,457.71 | 1,584.99 | 1,723.36 | 1,873.79 | 2,037.33 | 2,215.11 | 2,408.38 |
| Asia Pacific | 869 | 959.46 | 1,059.18 | 1,169.11 | 1,290.27 | 1,423.80 | 1,570.95 | 1,733.09 | 1,911.74 | 2,108.54 | 2,325.33 |
| LAMEA | 347.60 | 379.23 | 413.74 | 451.39 | 492.47 | 537.28 | 586.18 | 639.52 | 697.72 | 761.21 | 830.48 |
| Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Colonoscopes | 1,216.60 | 1,319.73 | 1,431.55 | 1,552.79 | 1,684.24 | 1,826.77 | 1,981.27 | 2,148.78 | 2,330.37 | 2,527.21 | 2,740.57 |
| Gastroscopes | 1,042.80 | 1,141.49 | 1,249.50 | 1,367.72 | 1,497.11 | 1,638.72 | 1,793.70 | 1,963.32 | 2,148.96 | 2,352.13 | 2,574.48 |
| Bronchoscopes | 695.20 | 766.05 | 844.03 | 929.87 | 1,024.34 | 1,128.30 | 1,242.69 | 1,368.57 | 1,507.06 | 1,659.43 | 1,827.05 |
| Others | 521.40 | 565.06 | 612.34 | 663.55 | 719 | 779.06 | 844.09 | 914.51 | 990.76 | 1,073.30 | 1,162.67 |
| Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 2,085.60 | 2,267.81 | 2,465.90 | 2,681.27 | 2,915.42 | 3,169.98 | 3,446.71 | 3,747.58 | 4,074.66 | 4,430.22 | 4,816.76 |
| Ambulatory Surgical Centers/Clinics | 1,042.80 | 1,145.28 | 1,257.78 | 1,381.26 | 1,516.80 | 1,665.58 | 1,828.87 | 2,008.09 | 2,204.78 | 2,420.64 | 2,657.52 |
| Others | 347.60 | 379.23 | 413.74 | 451.39 | 492.47 | 537.28 | 586.18 | 639.52 | 697.72 | 761.21 | 830.48 |
| Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1,216.60 | 1,319.73 | 1,431.55 | 1,552.79 | 1,684.24 | 1,826.77 | 1,981.27 | 2,148.78 | 2,330.37 | 2,527.21 | 2,740.57 |
| Europe | 1,042.80 | 1,133.90 | 1,232.95 | 1,340.63 | 1,457.71 | 1,584.99 | 1,723.36 | 1,873.79 | 2,037.33 | 2,215.11 | 2,408.38 |
| Asia Pacific | 869 | 959.46 | 1,059.18 | 1,169.11 | 1,290.27 | 1,423.80 | 1,570.95 | 1,733.09 | 1,911.74 | 2,108.54 | 2,325.33 |
| LAMEA | 347.60 | 379.23 | 413.74 | 451.39 | 492.47 | 537.28 | 586.18 | 639.52 | 697.72 | 761.21 | 830.48 |
To get full access to our Market Insights, you need a Professional Account or a Business Suite.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Our customers work more efficiently and benefit from
